SLC2A1, SLC2A2 and SLC2A5 gene expression in mid-jejunal mucosa was measured to investigate whether intestinal glucose transporters could be influenced by diabetes, diet and/or metformin-pioglitazone medication and as such have an effect on the postprandial plasma glucose concentrations. This evidence concerns the gene SLC2A1 and diabetes mellitus.